Joint Synovial Fluid Metabolomics Method to Decipher the Metabolic Mechanisms of Adjuvant Arthritis and Geniposide Intervention
- 10 August 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 19 (9) , 3769-3778
Abstract
Rheumatoid arthritis (RA), a chronic systemic autoimmune disease, is mainly characterized by joint lesions and permanent loss of joint function. To discover the metabolic characteristics of RA and the underlying mechanisms in treatment with Geniposide (GE), untargeted metabolomic analysis based on hydrophilic interaction liquid chromatography coupled to high-resolution mass spectrometry (HILIC-HRMS) was performed using joint synovial fluid samples from adjuvant arthritis (AA) rats. Microdialysis (MD) was utilized to collect the dialysate samples precisely from the articular cavity of AA rats. Multivariate statistical analysis was then conducted to discover the metabolite changes induced by AA and to differentiate GE-related biomarkers. The mass spectrometry data are available on the Chorus website (https://chorusproject.org/pages/index.html) with the dataset identifier 1680. The results showed that 20 metabolites differed significantly between AA rats and normal rats. GE treatment recovered the altered levels of the 13 metabolites mentioned above, such as palmitoylethanolamide (PEA), Cer (d18:0/22:0), and PC (18:1(11Z)/16:1(9Z)), and normalized glycerophospholipid metabolism. As evidenced by western blotting, the changes in PEA levels adjusted by GE were associated with the down-regulated expression of N-acylethanolamine-hydrolyzing acid amidase (NAAA) in synovial tissues. Taken together, the elucidation of metabolic changes of joint synovial fluid and how this is influenced by GE will promote future therapeutic interventions of RA.Keywords
Funding Information
- National Natural Science Foundation of China (81473400, 81874360, 81903765)
This publication has 52 references indexed in Scilit:
- Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in miceArthritis Research & Therapy, 2013
- Design and Synthesis of Potent N-Acylethanolamine-hydrolyzing Acid Amidase (NAAA) Inhibitor as Anti-Inflammatory CompoundsPLOS ONE, 2012
- Metabolomics: the final frontier?Genome Medicine, 2012
- Elevated muscle interstitial levels of pain-inducing substances in symptomatic muscles in patients with polymyalgia rheumaticaPain, 2011
- Synthesis and Structure−Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase InhibitorsJournal of Medicinal Chemistry, 2010
- Methodological Aspects on Microdialysis Protein Sampling and Quantification in Biological Fluids: An In Vitro Study on Human Ventricular CSFAnalytical Chemistry, 2010
- Phospholipase A2 structure/function, mechanism, and signalingJournal of Lipid Research, 2009
- HMDB: a knowledgebase for the human metabolomeNucleic Acids Research, 2008
- The N‐Acylethanolamine‐Hydrolyzing Acid Amidase (NAAA)Chemistry & Biodiversity, 2007
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000